• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Grb7 gene amplification and protein expression by FISH and IHC in ovarian cancer.通过荧光原位杂交(FISH)和免疫组织化学(IHC)检测卵巢癌中Grb7基因扩增及蛋白表达情况
Int J Clin Exp Pathol. 2015 Sep 1;8(9):11296-304. eCollection 2015.
2
Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization.人乳腺癌中HER2及共扩增基因GRB7和MLN64的表达:定量实时逆转录PCR作为免疫组织化学和荧光原位杂交的诊断替代方法
Clin Cancer Res. 2005 Dec 1;11(23):8348-57. doi: 10.1158/1078-0432.CCR-05-0841.
3
Her-2/neu expression and amplification in early stage ovarian surface epithelial neoplasms.Her-2/neu在早期卵巢表面上皮性肿瘤中的表达及扩增
Gynecol Oncol. 2004 Dec;95(3):570-5. doi: 10.1016/j.ygyno.2004.08.043.
4
Differential functions of growth factor receptor-bound protein 7 (GRB7) and its variant GRB7v in ovarian carcinogenesis.生长因子受体结合蛋白 7(GRB7)及其变体 GRB7v 在卵巢癌发生中的差异功能。
Clin Cancer Res. 2010 May 1;16(9):2529-39. doi: 10.1158/1078-0432.CCR-10-0018. Epub 2010 Apr 13.
5
Methylation-associated silencing of promotes ovarian cancer aggressiveness by targeting GRB7 and MAPK/ERK pathways.甲基化相关沉默的 通过靶向 GRB7 和 MAPK/ERK 通路促进卵巢癌的侵袭性。
Theranostics. 2018 Jan 1;8(2):423-436. doi: 10.7150/thno.22377. eCollection 2018.
6
[Analysis of HER2 gene status in breast cancer with HER2 protein overexpression].[HER2蛋白过表达乳腺癌中HER2基因状态分析]
Zhonghua Bing Li Xue Za Zhi. 2006 Oct;35(10):584-8.
7
The gene copy number of c-MET has a significant impact on progression-free survival in Korean patients with ovarian carcinoma.c-MET基因拷贝数对韩国卵巢癌患者的无进展生存期有显著影响。
Hum Pathol. 2017 Jun;64:98-105. doi: 10.1016/j.humpath.2017.04.002. Epub 2017 Apr 17.
8
[Analysis of HER2 status in breast carcinoma using fully automated HER2 staining and fluorescence in-situ hybridization technology].[运用全自动HER2染色及荧光原位杂交技术分析乳腺癌中的HER2状态]
Zhonghua Bing Li Xue Za Zhi. 2012 May;41(5):296-300. doi: 10.3760/cma.j.issn.0529-5807.2012.05.003.
9
Human epidermal growth factor receptor 2 expression in breast cancer: correlation with clinical pathological features.人表皮生长因子受体2在乳腺癌中的表达:与临床病理特征的相关性
Int J Clin Exp Pathol. 2014 Dec 1;7(12):8740-7. eCollection 2014.
10
Comparison of immunohistochemical and fluorescence in situ hybridization assessment for HER-2/neu status in Taiwanese breast cancer patients.台湾乳腺癌患者中HER-2/neu状态的免疫组织化学与荧光原位杂交评估比较
Taiwan J Obstet Gynecol. 2007 Jun;46(2):146-51. doi: 10.1016/S1028-4559(07)60008-4.

引用本文的文献

1
GRB7 Plays a Vital Role in Promoting the Progression and Mediating Immune Evasion of Ovarian Cancer.GRB7在促进卵巢癌进展和介导免疫逃逸中发挥重要作用。
Pharmaceuticals (Basel). 2024 Aug 7;17(8):1043. doi: 10.3390/ph17081043.
2
Knockdown of growth factor receptor bound protein 7 suppresses angiogenesis by inhibiting the secretion of vascular endothelial growth factor A in ovarian cancer cells.生长因子受体结合蛋白 7 的敲低通过抑制血管内皮生长因子 A 在卵巢癌细胞中的分泌抑制血管生成。
Bioengineered. 2021 Dec;12(2):12179-12190. doi: 10.1080/21655979.2021.2005225.
3
Methylation-associated silencing of promotes ovarian cancer aggressiveness by targeting GRB7 and MAPK/ERK pathways.甲基化相关沉默的 通过靶向 GRB7 和 MAPK/ERK 通路促进卵巢癌的侵袭性。
Theranostics. 2018 Jan 1;8(2):423-436. doi: 10.7150/thno.22377. eCollection 2018.
4
Overexpression of PTK6 predicts poor prognosis in bladder cancer patients.PTK6的过表达预示着膀胱癌患者的预后不良。
J Cancer. 2017 Sep 27;8(17):3464-3473. doi: 10.7150/jca.21318. eCollection 2017.

本文引用的文献

1
Validation of analytical breast cancer microarray analysis in medical laboratory.
Med Oncol. 2014 Oct;31(10):201. doi: 10.1007/s12032-014-0201-7. Epub 2014 Sep 3.
2
Identification of druggable cancer driver genes amplified across TCGA datasets.在TCGA数据集中鉴定出扩增的可靶向癌症驱动基因。
PLoS One. 2014 May 29;9(5):e98293. doi: 10.1371/journal.pone.0098293. eCollection 2014.
3
Cancer statistics, 2014.癌症统计数据,2014 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7.
4
Dissecting GRB7-mediated signals for proliferation and migration in HER2 overexpressing breast tumor cells: GTP-ase rules.解析 GRB7 介导的信号通路在 HER2 过表达的乳腺癌肿瘤细胞中的增殖和迁移作用:GTP 酶规则。
Am J Cancer Res. 2013 Apr 3;3(2):173-95. Print 2013.
5
The discovery of phenylbenzamide derivatives as Grb7-based antitumor agents.苯甲酰胺衍生物作为 Grb7 为基础的抗肿瘤剂的发现。
ChemMedChem. 2013 Feb;8(2):280-8. doi: 10.1002/cmdc.201200400. Epub 2012 Dec 17.
6
Targeting GRB7/ERK/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cells.靶向 GRB7/ERK/FOXM1 信号通路抑制卵巢癌细胞的侵袭转移能力。
PLoS One. 2012;7(12):e52578. doi: 10.1371/journal.pone.0052578. Epub 2012 Dec 20.
7
Novel nonphosphorylated peptides with conserved sequences selectively bind to Grb7 SH2 domain with affinity comparable to its phosphorylated ligand.新型非磷酸化肽具有保守序列,可选择性地与 Grb7 SH2 结构域结合,亲和力可与其磷酸化配体相媲美。
PLoS One. 2012;7(1):e29902. doi: 10.1371/journal.pone.0029902. Epub 2012 Jan 11.
8
Interaction of the non-phosphorylated peptide G7-18NATE with Grb7-SH2 domain requires phosphate for enhanced affinity and specificity.非磷酸化肽 G7-18NATE 与 Grb7-SH2 结构域的相互作用需要磷酸基团来增强亲和力和特异性。
J Mol Recognit. 2012 Jan;25(1):57-67. doi: 10.1002/jmr.2148.
9
GRB7 is required for triple-negative breast cancer cell invasion and survival.GRB7 对于三阴性乳腺癌细胞的侵袭和存活是必需的。
Breast Cancer Res Treat. 2012 Jun;133(2):607-15. doi: 10.1007/s10549-011-1822-6. Epub 2011 Oct 18.
10
Structural basis of binding by cyclic nonphosphorylated peptide antagonists of Grb7 implicated in breast cancer progression.环状非磷酸化肽拮抗剂与 Grb7 结合的结构基础,Grb7 与乳腺癌的进展有关。
J Mol Biol. 2011 Sep 23;412(3):397-411. doi: 10.1016/j.jmb.2011.07.030. Epub 2011 Jul 23.

通过荧光原位杂交(FISH)和免疫组织化学(IHC)检测卵巢癌中Grb7基因扩增及蛋白表达情况

Grb7 gene amplification and protein expression by FISH and IHC in ovarian cancer.

作者信息

Zeng Manman, Yang Zhu, Hu Xiaoyu, Liu Yi, Yang Xiaotao, Ran Hailong, Li Yanan, Li Xu, Yu Qiubo

机构信息

Department of Gynecology, The Second Affiliated Hospital of Chongqing Medical University Chongqing, P. R. China.

Molecular Medical Laboratory, Chongqing Medical University Chongqing, P. R. China.

出版信息

Int J Clin Exp Pathol. 2015 Sep 1;8(9):11296-304. eCollection 2015.

PMID:26617853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4637669/
Abstract

OBJECTIVE

Overexpression of growth factor receptor-bound protein 7 (Grb7) has been found in numerous human cancers. The aim of this study was to evaluate the correlation between Grb7 gene amplification and protein expression in ovarian cancer (OC).

METHODS

We use Tissue Microarray (TMA) respectively to detect the gene amplification and protein expression of Grb7 in 90 cases OC and 10 control specimens of normal ovarian tissues by IHC and FISH.

RESULTS

The Grb7 protein expression by IHC analysis was observed in 52/90 (57.8%) OC with 3 cases (3.3%) scored 3(+) and 9 cases (10%) scored 2(+) Grb7 gene amplification by FISH analysis was successfully detectable in 6 specimens with a positive rate of 6.8% (6/88) in which immunostaining 3(+), 2(+) and negative (1(+)/0) expressions of Grb7 were 100.0% (3/3), 11.1% (1/9) and 2.6% (2/76), respectively. Our data exhibited that the IHC and FISH results had a good consistency between Grb7 gene amplification and Grb7 protein expression (Kappa = 0.651, P < 0.001). Both the results of IHC and FISH revealed that Grb7 did not seem to have a role in OC clinicopathology.

CONCLUSION

There is a close relationship between Grb7 gene amplification and GRB7 protein overexpression in human OC. IHC might have limited diagnostic value especially in these tumors and especially in characterizing genetically diverse borderline cases, FISH could be superior to IHC.

摘要

目的

在多种人类癌症中均发现生长因子受体结合蛋白7(Grb7)过表达。本研究旨在评估卵巢癌(OC)中Grb7基因扩增与蛋白表达之间的相关性。

方法

我们分别使用组织微阵列(TMA),通过免疫组化(IHC)和荧光原位杂交(FISH)检测90例OC组织和10例正常卵巢组织对照标本中Grb7的基因扩增和蛋白表达。

结果

免疫组化分析显示,90例OC中有52例(57.8%)出现Grb7蛋白表达,其中3例(3.3%)评分为3(+),9例(10%)评分为2(+)。FISH分析成功检测到6个标本中有Grb7基因扩增,阳性率为6.8%(6/88),其中Grb7免疫染色3(+)、2(+)和阴性(1(+)/0)表达分别为100.0%(3/3)、11.1%(1/9)和2.6%(2/76)。我们的数据表明,Grb7基因扩增与Grb7蛋白表达之间,免疫组化和FISH结果具有良好的一致性(Kappa = 0.651,P < 0.001)。免疫组化和FISH结果均显示,Grb7似乎在OC临床病理学中不起作用。

结论

在人类OC中,Grb7基因扩增与GRB7蛋白过表达之间存在密切关系。免疫组化的诊断价值可能有限,尤其是在这些肿瘤中,特别是在鉴别基因多样的交界性病例时,荧光原位杂交可能优于免疫组化。